NCT00840268View on ClinicalTrials.gov

A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

427

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Dry Eye
Interventions
DRUG

Hydroxypropyl Guar Galactomannan (HPGG) 0.25% ophthalmic gel

DRUG

Hydroxypropyl Guar Galactomannan Vehicle

Inactive ingredients used as a placebo comparator

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00840268 - A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye Patients | Biotech Hunter | Biotech Hunter